202 related articles for article (PubMed ID: 17600821)
1. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.
Ek ET; Dass CR; Contreras KG; Choong PF
J Orthop Res; 2007 Dec; 25(12):1671-80. PubMed ID: 17600821
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
Ek ET; Dass CR; Contreras KG; Choong PF
Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
[TBL] [Abstract][Full Text] [Related]
3. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
Dass CR; Contreras KG; Dunstan DE; Choong PF
Biomaterials; 2007 Jul; 28(19):3026-33. PubMed ID: 17408737
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
[TBL] [Abstract][Full Text] [Related]
5. Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer.
Filleur S; Volz K; Nelius T; Mirochnik Y; Huang H; Zaichuk TA; Aymerich MS; Becerra SP; Yap R; Veliceasa D; Shroff EH; Volpert OV
Cancer Res; 2005 Jun; 65(12):5144-52. PubMed ID: 15958558
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.
Takenaka K; Yamagishi S; Jinnouchi Y; Nakamura K; Matsui T; Imaizumi T
Life Sci; 2005 Nov; 77(25):3231-41. PubMed ID: 15985268
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
Guan M; Pang CP; Yam HF; Cheung KF; Liu WW; Lu Y
Cancer Gene Ther; 2004 May; 11(5):325-32. PubMed ID: 15044958
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
Garcia M; Fernandez-Garcia NI; Rivas V; Carretero M; Escamez MJ; Gonzalez-Martin A; Medrano EE; Volpert O; Jorcano JL; Jimenez B; Larcher F; Del Rio M
Cancer Res; 2004 Aug; 64(16):5632-42. PubMed ID: 15313901
[TBL] [Abstract][Full Text] [Related]
10. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.
Abramson LP; Stellmach V; Doll JA; Cornwell M; Arensman RM; Crawford SE
J Pediatr Surg; 2003 Mar; 38(3):336-42; discussion 336-42. PubMed ID: 12632345
[TBL] [Abstract][Full Text] [Related]
11. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.
Ek ET; Dass CR; Choong PF
Trends Mol Med; 2006 Oct; 12(10):497-502. PubMed ID: 16962374
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential.
Barnstable CJ; Tombran-Tink J
Prog Retin Eye Res; 2004 Sep; 23(5):561-77. PubMed ID: 15302351
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
15. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.
Yang H; Xu Z; Iuvone PM; Grossniklaus HE
Mol Vis; 2006 May; 12():511-7. PubMed ID: 16735992
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Oncol Rep; 2005 Dec; 14(6):1615-9. PubMed ID: 16273265
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor.
Ek ET; Dass CR; Contreras KG; Choong PF
Clin Exp Metastasis; 2007; 24(2):93-106. PubMed ID: 17458711
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic therapy for osteosarcoma.
Quan GM; Choong PF
Cancer Metastasis Rev; 2006 Dec; 25(4):707-13. PubMed ID: 17160710
[TBL] [Abstract][Full Text] [Related]
19. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions.
Tong JP; Yao YF
Clin Biochem; 2006 Mar; 39(3):267-76. PubMed ID: 16409998
[TBL] [Abstract][Full Text] [Related]
20. Fas expression inversely correlates with metastatic potential in osteosarcoma cells.
Worth LL; Lafleur EA; Jia SF; Kleinerman ES
Oncol Rep; 2002; 9(4):823-7. PubMed ID: 12066216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]